Antipodes Partners’s Cencora COR Stock Holding History
Bought
Maintained
Sold
Other funds holding COR
Antipodes Partners's COR Position: Q2 2026 in Review
Antipodes Partners increased its Cencora (COR) stake by 59% in Q2 2026, buying an estimated $57.1K and bringing the position to 531 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #99.
Antipodes Partners first reported a position in COR in Q1 2020 and has held it in 23 quarters since. The position peaked at $125M in Q4 2023. 1,343 funds tracked by Wall St. Rank hold COR as of Q2 2026.
- Antipodes Partners held 531 shares of Cencora worth $150K as of Q2 2026.
- Antipodes Partners bought 198 Cencora shares in Q2 2026, an estimated $57.1K.
- Cencora made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #99 holding.
- Antipodes Partners first reported a position in Cencora in Q1 2020 and has held it in 23 quarters since.
- Antipodes Partners's Cencora position peaked at $125M in Q4 2023.
- 1,343 funds tracked by Wall St. Rank held Cencora as of Q2 2026.
Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.